Champions Oncology (CSBR) Other Operating Expenses (2010 - 2026)

Champions Oncology has reported Other Operating Expenses for 17 years, with the latest figure at -$1000.0 in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 99.66% year-over-year to -$1000.0 in Q2 2026; TTM through Apr 2026 was -$110000.0, a 62.46% increase from a year earlier, with the FY2026 full-year figure at -$111000.0, up 62.12% from the prior year.
• Other Operating Expenses was -$1000.0 for Q2 2026 at Champions Oncology, up from -$89000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $10.0 million in Q2 2023, with the low at -$293000.0 in Q2 2025.
• Average Other Operating Expenses over 5 years is $6.4 million, with a median of $8.6 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses sank 103.1% in 2025, then jumped 99.66% in 2026.
• Over 5 years, Other Operating Expenses stood at $9.1 million in 2022, then fell by 7.98% to $8.4 million in 2023, then advanced by 12.46% to $9.5 million in 2024, then plunged by 100.21% to -$20000.0 in 2025, then soared by 95.0% to -$1000.0 in 2026.
• The last three Other Operating Expenses figures came in at -$1000.0 (Q2 2026), -$89000.0 (Q1 2026), and -$20000.0 (Q3 2025), per Business Quant data.